Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02694757 · ClinicalTrials.gov registry record · NA
Efficacy of Ostom-i Alert System at Decreasing Dehydration Related Complications
A NA study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT02694757: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT02694757 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02694757, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of the Ostom-i device in decreasing readmission rates of subjects with new ileostomies in the first 30 days post-operatively.
Interventions
- DEVICE Ostom-i device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2019-03-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02694757
The ClinicalTrials.gov registry entry for NCT02694757 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ostom-i device is the first listed.
NCT02694757 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02694757 about?
NCT02694757 is a clinical study titled "Efficacy of Ostom-i Alert System at Decreasing Dehydration Related Complications". The purpose of this study is to evaluate the efficacy of the Ostom-i device in decreasing readmission rates of subjects with new ileostomies in the first 30 days post-operatively.
What is the current status of trial NCT02694757?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2017-08-01. Estimated completion is 2019-03-04.
What interventions are being tested in trial NCT02694757?
The interventions under investigation include: Ostom-i device (DEVICE).
Who is sponsoring clinical trial NCT02694757?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.